AL-S Pharma AG | Finanzwire

Basculer en Français

10184	Companies
209529	Keywords
139629	Articles
111067	Press releases

Home
Companies
AL-S Pharma AG

BRIEF

published on 03/19/2026 at 07:35, 21 days 9 hours ago

AL-S Pharma's AP-101 Shows Promise in ALS Treatment

Clinical Trial ALS Treatment Phase 2 Data AP-101 SOD1 Targeting
PRESS RELEASE

published on 03/19/2026 at 07:30, 21 days 9 hours ago

Additional Phase 2 Data of AL-S Pharma’s Lead Program AP-101 Further Demonstrate Clinically Meaningful Disease Modification and Prolonged Survival in ALS
AL-S Pharma AG presents additional Phase 2 data of lead program AP-101 at AD/PD International Conference showing disease modification in ALS patients. AP-101 targets misfolded SOD1 to inhibit disease progression

ALS Phase 2 Data AP-101 AL-S Pharma AG SOD1

Accesswire

Published on 04/09/2026 at 16:00, 48 minutes ago

Banff Half Marathon Completes 2025 Emissions Assessment, Supporting Climate Action with Karbon-X
Published on 04/09/2026 at 14:40, 2 hours 8 minutes ago

Silver X Delivers Production Growth During the First Quarter of 2026
Published on 04/09/2026 at 14:00, 2 hours 48 minutes ago

Orogen Royalties Announces Mineral Reserve and Resource Update on Producing Ermitaño Royalty
Published on 04/09/2026 at 13:30, 3 hours 18 minutes ago

Datametrex Receives $6M Purchase Order for Data Centre from Fortune 500 Conglomerate
Published on 04/09/2026 at 13:30, 3 hours 18 minutes ago

ESGold Advances Toward Production and Exploration Drilling as Mill Buildout Progresses in Parallel

View all ACCESSWIRE

EQS Group

Published on 04/09/2026 at 15:59, 48 minutes ago

Cairn Homes Plc: Holding(s) in Company
Published on 04/09/2026 at 15:57, 51 minutes ago

Cairn Homes Plc: Holding(s) in Company
Published on 04/09/2026 at 15:40, 1 hour 8 minutes ago

Form 8.3 - The Vanguard Group, Inc.: LondonMetric Property plc
Published on 04/09/2026 at 15:39, 1 hour 8 minutes ago

Form 8.3 - The Vanguard Group, Inc.: Schroders plc
Published on 04/09/2026 at 15:39, 1 hour 8 minutes ago

Form 8.3 - The Vanguard Group, Inc.: British Land Company plc, The

Les Echos

Published on 04/09/2026 at 15:57, 50 minutes ago

Filing of CNP Assurances SA 2025 universal registration document and 2025 Solvency and Financial Condition Reports
Published on 04/09/2026 at 07:00, 9 hours 48 minutes ago

bioMérieux Unveils its BIOFIRE® SPOTFIRE® Molecular Testing Solution for the Pharmaceutical Industry, Redefining Rapid Mycoplasma Testing
Published on 04/08/2026 at 18:02, 22 hours 46 minutes ago

Publication of the 2025 Universal Registration Document
Published on 04/08/2026 at 17:45, 23 hours 3 minutes ago

DISCLOSURE OF SHARE CAPITAL AND VOTING RIGHTS
Published on 04/08/2026 at 12:58, 1 day 3 hours ago

EURAZEO IS ASSIGNED A BBB CREDIT RATING (STABLE OUTLOOK) BY S&P AND A BBB CREDIT RATING (STABLE OUTLOOK) BY FITCH

View all LES ECHOS COMFI WIRE